BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24144287)

  • 21. Morphometry in the cytologic evaluation of thyroid follicular lesions.
    Nagashima T; Suzuki M; Oshida M; Hashimoto H; Yagata H; Shishikura T; Koda K; Nakajima N
    Cancer; 1998 Apr; 84(2):115-8. PubMed ID: 9570215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follicular thyroid lesions, elements that affect both diagnosis and prognosis.
    Zeiger MA; Dackiw AP
    J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of minimally invasive follicular carcinomas by gene profiling.
    Lubitz CC; Gallagher LA; Finley DJ; Zhu B; Fahey TJ
    Surgery; 2005 Dec; 138(6):1042-8; discussion 1048-9. PubMed ID: 16360389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
    Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
    J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular thyroid carcinoma.
    Sobrinho-Simões M; Eloy C; Magalhães J; Lobo C; Amaro T
    Mod Pathol; 2011 Apr; 24 Suppl 2():S10-8. PubMed ID: 21455197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular neoplasms of the thyroid: view, biases, and experiences.
    LiVolsi VA; Baloch ZW
    Adv Anat Pathol; 2004 Nov; 11(6):279-87. PubMed ID: 15505528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual tumors of the thyroid gland.
    Baloch ZW; LiVolsi VA
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fifteen percent issue in molecular-based diagnosis of follicular thyroid carcinoma.
    Takano T
    Pathol Int; 2011 Mar; 61(3):165-6. PubMed ID: 21355960
    [No Abstract]   [Full Text] [Related]  

  • 31. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular neoplasm of the thyroid--vanishing cytologic diagnosis?
    Kapur U; Wojcik EM
    Diagn Cytopathol; 2007 Aug; 35(8):525-8. PubMed ID: 17636488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report.
    Juhlin CC; Bränström R; Shabo I; Höög A
    Int J Surg Pathol; 2019 May; 27(3):290-293. PubMed ID: 30370813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pitfalls in the diagnosis of follicular epithelial proliferations of the thyroid.
    Mete O; Asa SL
    Adv Anat Pathol; 2012 Nov; 19(6):363-73. PubMed ID: 23060062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC; Cerutti JM
    Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.
    Komatsu M; Hanamura N; Tsuchiya S; Seki T; Kuroda T
    Radiat Med; 1994; 12(6):293-9. PubMed ID: 7724824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
    Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
    Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.
    Ito Y; Yoshida H; Uruno T; Nakano K; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
    Oncol Rep; 2003; 10(5):1337-40. PubMed ID: 12883703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer.
    Liska J; Altanerova V; Galbavy S; Stvrtina S; Brtko J
    Endocr Regul; 2005 Sep; 39(3):73-83. PubMed ID: 16468229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
    Pallante P; Visone R; Croce CM; Fusco A
    Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.